未登录

A

Anand R. Shewale

University of Arkansas System

H指数:13

被引数:634

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patients' experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson's disease

患者对帕金森病患者长期使用左旋多巴/卡比多巴磷酸酯连续皮下输注的体验与看法

JOURNAL OF NEUROLOGY

IF4.6

2025-05-220

OA

Ubrogepant users' real-world experience: Patients on ubrogepant, characteristics and outcomes (UNIVERSE) study

IF4

2024-09-261

OAAI

Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine

IF4.6

2024-02-271

OA

Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-04-258

OAAI

Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks

IF4

2021-11-282

PREAI

Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data

患有心血管疾病和禁忌症的偏头痛患者: 对真实世界索赔数据的分析

JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH

IF2.5

2020-10-2337

OAAI

Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response

IF4.6

2020-03-2924

OAAI

Acute treatment patterns in patients with migraine newly initiating a triptan

IF4.6

2020-03-0518

OAAI

Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II

IF4

2020-02-1948

OAAI

Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients

IF4.6

2019-03-0911

OAAI

PREDICTIVE FACTORS FOR MULTIDRUG-RESISTANT PNEUMONIA IN CRITICALLY ILL PATIENTS: THE DEFINE STUDY

CRITICAL CARE MEDICINE

IF6

2018-01-010

PREAI

Comparative Effectiveness of Intra-Articular Hyaluronic Acid and Corticosteroid Injections on the Time to Surgical Knee Procedures

JOURNAL OF ARTHROPLASTY

IF3.8

2017-12-0115

PREAI

Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery

JOURNAL OF ARTHROPLASTY

IF3.8

2017-10-0123

OAAI

Letter to the Editor on 'Hyaluronic Acid Injections in Medicare Knee Osteoarthritis Patients Are Associated With Longer Time to Knee Arthroplasty'

JOURNAL OF ARTHROPLASTY

IF3.8

2017-02-012

OAAI

Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients

IF8.9

2016-06-0151

OAAI

A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras

IF3.8

2016-05-0628

PREAI

CHARACTERIZATION OF MALE AND FEMALE USERS OF TESTOSTERONE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

VALUE IN HEALTH

IF6

2016-05-010

PREAI

GEOGRAPHIC VARIATION IN ON-LABEL AND OFF-LABEL TESTOSTERONE USE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

VALUE IN HEALTH

IF6

2016-05-010

OAAI

CHARACTERIZATION OF ON-LABEL AND OFF-LABEL USE OF TESTOSTERONE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

VALUE IN HEALTH

IF6

2016-05-010

OAAI

CHARACTERIZATION OF INITIAL TREATMENT STRATEGIES USED TO MANAGE INCIDENT KNEE OSTEOARTHRITIS

VALUE IN HEALTH

IF6

2016-05-012

PREAI